Bedia Akosman

468 total citations
6 papers, 201 citations indexed

About

Bedia Akosman is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bedia Akosman has authored 6 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Bedia Akosman's work include Studies on Chitinases and Chitosanases (4 papers), Peptidase Inhibition and Analysis (3 papers) and Extracellular vesicles in disease (1 paper). Bedia Akosman is often cited by papers focused on Studies on Chitinases and Chitosanases (4 papers), Peptidase Inhibition and Analysis (3 papers) and Extracellular vesicles in disease (1 paper). Bedia Akosman collaborates with scholars based in United States, Japan and Germany. Bedia Akosman's co-authors include Chun Geun Lee, Jack A. Elias, Suchitra Kamle, Chang-Min Lee, Bing Ma, Patrick Mucka, Junli Liu, Sang Won Park, Chuan He and Koji Taniguchi and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Bedia Akosman

6 papers receiving 201 citations

Peers

Bedia Akosman

MB

IMMUN

ONCOL

EPIDE

CB

Stephanie Vargas Aguilar Germany

Laura Seclì Italy

Ming-Lun Kang Taiwan

Larissa Hering Switzerland

Christopher R. Sutton Australia

Kalina Andreeva United States

Hong Bae Jeon South Korea

Joseph Willson United States

Yanxiang Meng Australia

Sevana Khaloian Germany

Stephanie Vargas Aguilar Germany

Bedia Akosman

96 ×0.8

MB

77 ×1.1

IMMUN

27 ×0.7

ONCOL

65 ×1.7

EPIDE

22 ×0.6

CB

Citations per year, relative to Bedia Akosman Bedia Akosman (= 1×) peers Stephanie Vargas Aguilar

Countries citing papers authored by Bedia Akosman

Since Specialization

Citations

This map shows the geographic impact of Bedia Akosman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bedia Akosman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bedia Akosman more than expected).

Fields of papers citing papers by Bedia Akosman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bedia Akosman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bedia Akosman. The network helps show where Bedia Akosman may publish in the future.

Co-authorship network of co-authors of Bedia Akosman

This figure shows the co-authorship network connecting the top 25 collaborators of Bedia Akosman. A scholar is included among the top collaborators of Bedia Akosman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bedia Akosman. Bedia Akosman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Akosman, Bedia, Jia‐Shu Chen, Suchitra Kamle, et al.. (2023). Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma. Cancer Research. 83(12). 1984–1999. 29 indexed citations

2.

Lee, Jae‐Hyun, Chang-Min Lee, Mun-Ock Kim, et al.. (2022). Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 67(3). 309–319. 10 indexed citations

3.

Ma, Bing, Suchitra Kamle, Bedia Akosman, et al.. (2022). CHI3L1 enhances melanoma lung metastasis via regulation of T cell co-stimulators and CTLA-4/B7 axis. Frontiers in Immunology. 13. 1056397–1056397. 18 indexed citations

4.

Kamle, Suchitra, Bing Ma, Chuan He, et al.. (2021). Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. JCI Insight. 6(21). 24 indexed citations

5.

Ma, Bing, Bedia Akosman, Suchitra Kamle, et al.. (2021). CHI3L1 regulates PD-L1 and anti–CHI3L1–PD-1 antibody elicits synergistic antitumor responses. Journal of Clinical Investigation. 131(21). 41 indexed citations

6.

Liu, Junli, Dorina Ibi, Koji Taniguchi, et al.. (2016). Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction. Cell. 167(4). 1052–1066.e18. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact